Ovarian cancer screening
Open Access
- 17 August 2004
- journal article
- review article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 171 (4) , 323-324
- https://doi.org/10.1503/cmaj.1031298
Abstract
Ovarian cancer is generally detected at an advanced stage and is associated with a 5-year survival rate of about 30%. However, survival rates of greater than 90% have been reported with stage I disease, thus fuelling efforts to determine the role of population screening for the detection of earlyThis publication has 12 references indexed in Scilit:
- Screening for Ovarian Cancer: Recommendation StatementAnnals of Family Medicine, 2004
- Use of morphology to characterize and manage common adnexal massesBest Practice & Research Clinical Obstetrics & Gynaecology, 2004
- The use of mathematical models to evaluate pelvic masses; can they beat an expert operator?Best Practice & Research Clinical Obstetrics & Gynaecology, 2004
- Frequency and type of adnexal lesions in autopsy material from postmenopausal women: ultrasound study with histological correlationUltrasound in Obstetrics & Gynecology, 2003
- Calculation of the Risk of Ovarian Cancer From Serial CA-125 Values for Preclinical Detection in Postmenopausal WomenJournal of Clinical Oncology, 2003
- Screening for ovarian cancerExpert Review of Anticancer Therapy, 2003
- Design and evolution of the data management systems in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trialControlled Clinical Trials, 2000
- Screening for ovarian cancer: a pilot randomised controlled trialThe Lancet, 1999
- Small Cystic Pelvic Masses in Older Women: Is Surgical Removal Necessary?Gynecologic Oncology, 1998
- The Malignant Potential of Small Cystic Ovarian Tumors in Women over 50 Years of AgeGynecologic Oncology, 1998